Literature DB >> 28677152

Significant augmentation of regulatory T cell numbers occurs during the early neonatal period.

S Hayakawa1, N Ohno1, S Okada1, M Kobayashi1.   

Abstract

Regulatory T cells (Tregs ) control immune responses by suppressing various inflammatory cells. Tregs in newborn babies may play an important role in preventing excessive immune responses during their environmental change. We examined the number and phenotype of Tregs during the neonatal period in 49 newborn babies. Tregs were characterized by flow cytometry using cord blood (CB) and peripheral blood (PB) from the early (7-8 days after birth) and late (2-4 weeks after birth) neonatal periods. CD4+ forkhead box protein 3 (FoxP3+ ) T cells were classified into resting Tregs (CD45RA+ FoxP3low ), activated Tregs (CD45RA- FoxP3high ) and newly activated T cells (CD45RA- FoxP3low ). Compared with CB and PB during the late neonatal period, the percentage of Tregs and all Treg subpopulations in the CD4+ lymphocyte population were increased significantly during the early neonatal period. Furthermore, the proportion and absolute number of activated Tregs were increased markedly compared with other Treg subpopulations, such as resting Tregs and newly activated T cells (non-Tregs ), in the early neonatal period. Increased Tregs concomitantly expressed the suppressive molecule cytotoxic T lymphocyte antigen-4 (CTLA-4). The up-regulated expression of chemokine receptor 4 (CCR4) and down-regulated expression of CCR7 were also observed in expanded Tregs . When cord blood cells were cultured in vitro with CD3 monoclonal antibodies (mAb) for 5 days, CD4+ CD45RA- FoxP3high cells were increased significantly during the culture. Thus, the presence of increased activated Tregs in early neonates may play an important role in immunological regulation by suppressing excessive T cell activation caused by the immediate exposure to ubiquitous antigens after birth.
© 2017 British Society for Immunology.

Entities:  

Keywords:  FoxP3; immune regulation; neonates

Mesh:

Substances:

Year:  2017        PMID: 28677152      PMCID: PMC5629449          DOI: 10.1111/cei.13008

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Intrauterine growth restriction and prematurity influence regulatory T cell development in newborns.

Authors:  Dhriti Mukhopadhyay; Laura Weaver; Richard Tobin; Stephanie Henderson; Madhava Beeram; M Karen Newell-Rogers; Lena Perger
Journal:  J Pediatr Surg       Date:  2014-02-22       Impact factor: 2.545

2.  Neonatal regulatory T cells have reduced capacity to suppress dendritic cell function.

Authors:  Cesar M Rueda; Maria E Moreno-Fernandez; Courtney M Jackson; Suhas G Kallapur; Alan H Jobe; Claire A Chougnet
Journal:  Eur J Immunol       Date:  2015-06-25       Impact factor: 5.532

Review 3.  Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease.

Authors:  Trevor D Burt
Journal:  Am J Reprod Immunol       Date:  2013-02-25       Impact factor: 3.886

4.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates.

Authors:  Cesar M Rueda; Casey B Wells; Tate Gisslen; Alan H Jobe; Suhas G Kallapur; Claire A Chougnet
Journal:  Hum Immunol       Date:  2014-11-08       Impact factor: 2.850

6.  Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses.

Authors:  Guillaume Darrasse-Jèze; Gilles Marodon; Benoît L Salomon; Martin Catala; David Klatzmann
Journal:  Blood       Date:  2005-02-24       Impact factor: 22.113

Review 7.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

8.  CD4⁺ CD45RA⁻ FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes.

Authors:  F Haseda; A Imagawa; Y Murase-Mishiba; J Terasaki; T Hanafusa
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

9.  Developmental changes of FOXP3-expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations.

Authors:  Tatsuya Fuchizawa; Yuichi Adachi; Yasunori Ito; Hiroyuki Higashiyama; Hirokazu Kanegane; Takeshi Futatani; Ichiro Kobayashi; Yoshiro Kamachi; Tatsuo Sakamoto; Ikuya Tsuge; Hiroshi Tanaka; Alison H Banham; Hans D Ochs; Toshio Miyawaki
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

10.  Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid.

Authors:  Ling Lu; Xiaohui Zhou; Julie Wang; Song Guo Zheng; David A Horwitz
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

View more
  16 in total

1.  A wave of Foxp3+ regulatory T cell accumulation in the neonatal liver plays unique roles in maintaining self-tolerance.

Authors:  Mingyang Li; Weijia Zhao; Yifan Wang; Lixue Jin; Gaowen Jin; Xiuyuan Sun; Wei Wang; Ke Wang; Xi Xu; Jie Hao; Rong Jin; Wenxian Fu; Ying Sun; Yingjun Chang; Xiaojun Huang; Xuyu Zhou; Hounan Wu; Kunshan Zhang; Qing Ge
Journal:  Cell Mol Immunol       Date:  2019-06-06       Impact factor: 11.530

2.  Stereotypic Expansion of T Regulatory and Th17 Cells during Infancy Is Disrupted by HIV Exposure and Gut Epithelial Damage.

Authors:  Sonwabile Dzanibe; Katie Lennard; Agano Kiravu; Melanie S S Seabrook; Berenice Alinde; Susan P Holmes; Catherine A Blish; Heather B Jaspan; Clive M Gray
Journal:  J Immunol       Date:  2021-11-24       Impact factor: 5.422

3.  Higher Frequency and Increased Expression of Molecules Associated with Suppression on T Regulatory Cells from Newborn Compared with Adult Nonhuman Primates.

Authors:  Beth C Holbrook; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2020-09-02       Impact factor: 5.422

4.  Possible involvement of regulatory T cell abnormalities and variational usage of TCR repertoire in children with autoimmune neutropenia.

Authors:  S Goda; S Hayakawa; S Karakawa; S Okada; H Kawaguchi; M Kobayashi
Journal:  Clin Exp Immunol       Date:  2020-12-27       Impact factor: 5.732

Review 5.  Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome.

Authors:  Wendy Fonseca; Nicholas W Lukacs; Catherine Ptaschinski
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

Review 6.  Challenges for the Newborn Immune Response to Respiratory Virus Infection and Vaccination.

Authors:  Kali F Crofts; Martha A Alexander-Miller
Journal:  Vaccines (Basel)       Date:  2020-09-24

Review 7.  T cell Tolerance in Early Life.

Authors:  Lijun Yang; Rong Jin; Dan Lu; Qing Ge
Journal:  Front Immunol       Date:  2020-11-20       Impact factor: 7.561

8.  Clinical and Immunological Metrics During Pediatric Rhesus Macaque Development.

Authors:  Kristen M Merino; Nadia Slisarenko; Joshua M Taylor; Kathrine P Falkenstein; Margaret H Gilbert; Rudolf P Bohm; James L Blanchard; Amir Ardeshir; Elizabeth S Didier; Woong-Ki Kim; Marcelo J Kuroda
Journal:  Front Pediatr       Date:  2020-07-16       Impact factor: 3.418

Review 9.  Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.

Authors:  Ilenia Pacella; Silvia Piconese
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

10.  Impaired functional capacity of polarised neonatal macrophages.

Authors:  Stephan Dreschers; Kim Ohl; Nora Schulte; Klaus Tenbrock; Thorsten W Orlikowsky
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.